Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: Vaccine. 2007 Jan 24;25(17):3263–3269. doi: 10.1016/j.vaccine.2007.01.073

Table 3.

Increases in Granzyme B and IFN-γ ELISPOTS after Inactivated Vaccine With or Without QS21 Adjuvant1

Granzyme B sfc IFN-γ sfc
Vaccine Group H32 H12 B2 H32 H12 B2
QS Subjects
1 31 56 48 74 19 39
2 23 10 0 0 51 23
3 147 153 97 125 116 60
4 18 17 17 74 52 10
5 7 15 1 58 76 112
6 154 214 187 191 245 205
Aqueous Subjects
1 5 25 24 62 75 55
2 57 56 25 66 160 117
3 20 27 23 53 44 41
1

Mean no. sfc greater than 2 S.D. above the baseline mean; highest value at 2 or 4 weeks after vaccination

2

H3 = A/Panama (H3N2), H1 = A/New Caledonia (H1N1), B = B/Yamanashi